Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FVGSE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,663
Award facts
- Contract value 100% obligated
- $10,662.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location and a completion date of November 12, 2025. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected through open competition to fulfill this pharmaceutical requirement. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. This delivery order for Tagrisso, an oncology medication, aligns with the contractor's established role in providing specialized pharmaceutical products across multiple therapeutic domains to the Department of Defense health enterprise.
Quick answers
Who was awarded contract SPE2DB26FVGSE?
SPE2DB26FVGSE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FVGSE worth?
The government has obligated $10,663 on SPE2DB26FVGSE.
Is contract SPE2DB26FVGSE an order under another contract?
Yes. SPE2DB26FVGSE is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB26FVGSE competed?
The extent of competition for SPE2DB26FVGSE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award